ArticleJournal of medicinal chemistry2024

Computationally Driven Discovery of a BCR-ABL1 Kinase Inhibitor with Activity in Multidrug-Resistant Chronic Myeloid Leukemia.

Jarvis Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.